Decrease of hirudin degradation by deleting the KEX1 gene in recombinant Pichia pastoris
Research article published in Yeast (Chichester, England) (2008)
Abstract
Our previous study on recombinant hirudin production in Pichia pastoris demonstrated that, although the total productivity of hirudin was fairly high, its degradation was still severe, even if many engineering methods were applied to improve cell viability and reduce the release of intracellular proteinases. In this work, a pop-in/pop-out method, replacing the auxotrophic marker ARG4 gene with the resistant marker sh ble gene, was used to delete the KEX1 gene to reduce hirudin degradation in P. pastoris GS115Hir. Using this strategy, hirudin degradation was greatly decreased. At the same wet cell weight and cell viability, the percentage of intact hirudin Hir65 in total hirudin in strain GS115HirDeltakex1 was always kept as high as 90% in the initial stage of the methanol fermentation phase and above 62% even in the later stage of the methanol fermentation phase, whereas the percentage for the undeleted strain GS115Hir was only about 40% in the whole methanol fermentation phase. As a result, the intact hirudin Hir65 concentration could maximally reach 2.4 g/l in GS115HirDeltakex1 while it was only 1.1 g/l in GS115Hir.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Zusammenfassung
Our previous study on recombinant hirudin production in Pichia pastoris demonstrated that, although the total productivity of hirudin was fairly high, its degradation was still severe, even if many engineering methods were applied to improve cell viability and reduce the release of intracellular proteinases.
Warum dies für die Hirudotherapie relevant ist
Diese Studie untersuchte die Produktion von rekombinantem Hirudin in Pichia pastoris und prüfte insbesondere, ob die Deletion des KEX1-Gens den Abbau von intaktem Hirudin (Hir65) während der Methanolfermentation verringern kann. Der KEX1-deletierte Stamm hielt intaktes Hirudin zunächst bei etwa 90 % und in späteren Fermentationsstadien bei über 62 %, verglichen mit nur ~40 % im nicht-deletierten Stamm; die Konzentration an intaktem Hirudin erreichte 2,4 g/L gegenüber 1,1 g/L. Dies ist für das Fachgebiet der ASH hochrelevant, da es einen praktischen biotechnologischen Engpass bei der Herstellung eines zentralen aus Blutegeln gewonnenen Antikoagulans adressiert. Allerdings handelt es sich um eine Studie aus der industriellen Mikrobiologie und Fermentationsoptimierung ohne klinische oder tierexperimentelle Daten; ihre Relevanz beschränkt sich auf die rekombinante Produktion und nicht auf die therapeutische Anwendung der Hirudotherapie.
Zitation
Decrease of hirudin degradation by deleting the KEX1 gene in recombinant Pichia pastoris
Ni Z et al. · Yeast (Chichester, England), 2008
Verwandter klinischer Kontext
Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist
Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: 18. Juni 2026